LYNBROOK, N.Y., Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced its financial results for the third

ROCKLAND, Mass. and NEW YORK, Nov. 8, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluati

ROUND ROCK, Texas, Nov. 8, 2019 /PRNewswire/ -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies, announced new Phase 3 data today on its sublingual allergy immunotherapy (SLIT) portfolio, including efficacy and safety findings from the largest all

CRANFORD, N.J., Nov. 8, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ:  CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that the Company has issued its October 2019 Corporate Update Letter.  The Letter highlights the progress of the Com

WALTHAM, Mass., Nov. 8, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.19 per share.  The dividend will be paid on January 15, 2020, to shareholders of record as of D

NETANYA, Israel, Nov. 8, 2019 /PRNewswire/ -- Theranica Bio-Electronics Ltd., a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the American Headache Society published an article in its peer-reviewed journal,

SAN DIEGO, Nov. 8, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Company presented data from the Toca 6 Phase

SAN DIEGO and KALAMAZOO, Mich., Nov. 8, 2019 /PRNewswire/ -- Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, today announced data from its recently completed 12-month Phase 2b

SAN FRANCISCO, Nov. 8, 2019 /PRNewswire/ -- QB3 is proud to announce the 2019 cohort of the annual QB3 Biotech/Biopharma Pitch Summit, a group of early-stage companies chosen for their innovative technologies and potential market impact.This is the third year of the competition, which is open to life science startups based in California

LONDON, Nov. 8, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty. Compared with traditional solutions, dual mobility implants have a small diameter femoral head that locks into a larger polyethylene insert - increasing